HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Damaging Tumor Vessels with an Ultrasound-Triggered NO Release Nanosystem to Enhance Drug Accumulation and T Cells Infiltration.

AbstractINTRODUCTION:
Limited by tumor vascular barriers, restricted intratumoural T cell infiltration and nanoparticles accumulation remain major bottlenecks for anticancer therapy. Platelets are now known to maintain tumor vascular integrity. Therefore, inhibition of tumor-associated platelets may be an effective method to increase T cell infiltration and drug accumulation at tumor sites. Herein, we designed an ultrasound-responsive nitric oxide (NO) release nanosystem, SNO-HSA-PTX, which can release NO in response to ultrasound (US) irradiation, thereby inhibiting platelet function and opening the tumor vascular barrier, promoting drug accumulation and T cell infiltration.
METHODS:
We evaluated the ability of SNO-HSA-PTX to release NO in response to US irradiation. We also tested the effect of SNO-HSA-PTX on platelet function. Plenty of studies including cytotoxicity, pharmacokinetics study, biodistribution, blood perfusion, T cell infiltration, in vivo antitumor efficacy and safety assessment were conducted to investigate the antitumor effect of SNO-HSA-PTX.
RESULTS:
SNO-HSA-PTX with US irradiation inhibited tumor-associated platelets activation and induced openings in the tumor vascular barriers, which promoted the accumulation of SNO-HSA-PTX nanoparticles to the tumor sites. Meanwhile, the damaged vascular barriers allowed oxygen-carrying hemoglobin to infiltrate tumor regions, alleviating hypoxia of the tumor microenvironment. In addition, the intratumoral T cell infiltration was augmented, together with chemotherapy and NO therapy, which greatly inhibited tumor growth.
DISCUSSION:
Our research designed a simple strategy to open the vascular barrier by inhibiting the tumor-associated platelets, which provide new ideas for anti-tumor treatment.
AuthorsYan Xu, Jiwei Liu, Zhangya Liu, Guoguang Chen, Xueming Li, Hao Ren
JournalInternational journal of nanomedicine (Int J Nanomedicine) Vol. 16 Pg. 2597-2613 ( 2021) ISSN: 1178-2013 [Electronic] New Zealand
PMID33833514 (Publication Type: Journal Article)
Copyright© 2021 Xu et al.
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Nitroso Compounds
  • S-nitrosoalbumin, human
  • Nitric Oxide
  • Paclitaxel
  • Serum Albumin, Human
Topics
  • Animals
  • Antineoplastic Agents, Phytogenic (administration & dosage, pharmacokinetics, pharmacology)
  • Apoptosis
  • Breast Neoplasms (drug therapy, immunology, metabolism, pathology)
  • Cell Proliferation
  • Female
  • Humans
  • Lymphocytes, Tumor-Infiltrating (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Nanoparticles (administration & dosage, chemistry)
  • Nitric Oxide (metabolism)
  • Nitroso Compounds (chemistry)
  • Paclitaxel (administration & dosage, pharmacokinetics, pharmacology)
  • Serum Albumin, Human (chemistry)
  • Tissue Distribution
  • Tumor Cells, Cultured
  • Tumor Microenvironment (drug effects, immunology)
  • Ultrasonic Waves
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: